Microstructural changes after half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy

被引:2
作者
Esen, Ebru [1 ]
Sizmaz, Selcuk [1 ]
Demircan, Nihal [1 ]
机构
[1] Cukurova Univ, Sch Med, Dept Ophthalmol, Adana, Turkey
关键词
Central serous chorioretinopathy; Photodynamic therapy; Optical coherence tomography; Outer nuclear layer; Choroidal thickness; OPTICAL COHERENCE TOMOGRAPHY; SUBFOVEAL CHOROIDAL THICKNESS; PHOTORECEPTOR OUTER SEGMENT; MORPHOLOGIC CHANGES; NUCLEAR LAYER; VERTEPORFIN; EYES; OUTCOMES;
D O I
10.1016/j.pdpdt.2021.102347
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: To evaluate the retinal and choroidal microstructural changes at fovea after half-dose photodynamic therapy (PDT) in patients with chronic central serous chorioretinopathy (CSC), using optical coherence tomography (OCT). Methods: The study included 35 eyes with unilateral chronic CSC treated with half-dose PDT. The foveal outer nuclear layer (ONL) and subfoveal choroidal thickness (SFCT) in the affected eyes were compared with baseline measurements at month 1, 3, and 6 after half-dose PDT, and those of the healthy contralateral eyes. Results: The mean baseline ONL thickness of the affected eyes was thinner compared to unaffected fellow eyes (66.9 +/- 16.5 mu m vs 111.5 +/- 11.6 mu m, p<0.001), and increased significantly to 68.6 +/- 17.0 mu m at month 3 and 68.9 +/- 17.3 mu m at month 6 after treatment (p = 0.025 and p = 0.014 respectively). The mean baseline SFCT of the affected eyes was thicker compared to unaffected fellow eyes (399.9 +/- 87.0 mu m vs 338.2 +/- 75.4 mu m, p<0.001), and decreased significantly after treatment at month 1, 3, and 6 (374.0 +/- 84.8 mu m, 369.7 +/- 81.8 mu m, 367.3 +/- 80.8 mu m respectively, p<0.001 for all). The responder group (n = 26), in which subretinal fluid was completely resorbed, showed a significant increase in ONL thickness and decrease in SFCT after treatment, whereas in the non-responder group (n = 9) ONL thickness and SFCT did not differ after treatment. Conclusions: In CSC patients, significant changes are observed in foveal ONL thickness and SFCT after half-dose PDT. ONL thickness and SFCT are suggested to be considered in the OCT examinations of CSC patients.
引用
收藏
页数:6
相关论文
共 37 条
  • [1] OCT Risk Factors for 3-Year Development of Macular Complications in Eyes With "Resolved" Chronic Central Serous Chorioretinopathy
    Borrelli, Enrico
    Battista, Marco
    Sacconi, Riccardo
    Gelormini, Francesco
    Querques, Lea
    Grosso, Domenico
    Vella, Giovanna
    Bandello, Francesco
    Querques, Giuseppe
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2021, 223 : 129 - 139
  • [2] Optical coherence tomography angiography to assess vascular remodeling of the choriocapillaris after low-fluence photodynamic therapy for chronic central serous chorioretinopathy
    Cennamo, Gilda
    Cennamo, Michela
    Caputo, Giuseppe
    Mirra, Federica
    Pafundi, Pia Clara
    de Crecchio, Giuseppe
    Cennamo, Giovanni
    [J]. PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2019, 27 : 162 - 166
  • [3] Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level
    Chan, WM
    Lam, DSC
    Lai, TYY
    Tam, BSM
    Liu, DTL
    Chan, CKM
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2003, 87 (12) : 1453 - 1458
  • [4] Pachychoroid disease
    Cheung, Chui Ming Gemmy
    Lee, Won Ki
    Koizumi, Hideki
    Dansingani, Kunal
    Lai, Timothy Y. Y.
    Freund, K. Bailey
    [J]. EYE, 2019, 33 (01) : 14 - 33
  • [5] Morphologic changes in acute central serous chotioretinopathy evaluated by Fourier-domain optical coherence tomography
    Fujimoto, Hisataka
    Gomi, Fumi
    Wakabayashi, Taku
    Sawa, Miki
    Tsujikawa, Motokazu
    Tano, Yasuo
    [J]. OPHTHALMOLOGY, 2008, 115 (09) : 1494 - 1500
  • [6] One-Year Outcomes with Half-Dose Verteporfin Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
    Fujita, Kyoko
    Imamura, Yutaka
    Shinoda, Kei
    Matsumoto, Celso Soiti
    Mizutani, Yoshihiro
    Hashizume, Kouhei
    Mizota, Atsushi
    Yuzawa, Mitsuko
    [J]. OPHTHALMOLOGY, 2015, 122 (03) : 555 - 561
  • [7] Central serous chorioretinopathy: an update on pathogenesis and treatment
    Gemenetzi, M.
    De Salvo, G.
    Lotery, A. J.
    [J]. EYE, 2010, 24 (12) : 1743 - 1756
  • [8] EARLY CHANGES IN FOVEAL THICKNESS IN EYES WITH CENTRAL SEROUS CHORIORETINOPATHY
    Hata, Masayuki
    Oishi, Akio
    Shimozono, Masataka
    Mandai, Michiko
    Nishida, Akihiro
    Kurimoto, Yasuo
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2013, 33 (02): : 296 - 301
  • [9] Sufficient Evidence for Lymphatics in the Developing and Adult Human Choroid?
    Heindl, Ludwig M.
    Kaser-Eichberger, Alexandra
    Schlereth, Simona L.
    Bock, Felix
    Regenfuss, Birgit
    Reitsamer, Herbert A.
    McMenamin, Paul
    Lutty, Gerard A.
    Maruyama, Kazuichi
    Chen, Lu
    Dana, Reza
    Kerjaschki, Dontscho
    Alitalo, Kari
    De Stefano, Maria Egle
    Junghans, Barbara M.
    Schroedl, Falk
    Cursiefen, Claus
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (11) : 6709 - 6710
  • [10] ENHANCED DEPTH IMAGING OPTICAL COHERENCE TOMOGRAPHY OF THE CHOROID IN CENTRAL SEROUS CHORIORETINOPATHY
    Imamura, Yutaka
    Fujiwara, Takamitsu
    Margolis, Ron
    Spaide, Richard F.
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2009, 29 (10): : 1469 - 1473